Search clinical trials for: AD17002 Formulation buffer

Total 1453 results

Advagene Biopharma Co. Ltd.

Not yet recruiting

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Eosinophilic Asthma

Taiwan
Advagene Biopharma Co. Ltd.

Completed

Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19

COVID-19

Taiwan
Advagene Biopharma Co. Ltd.
Taipei Medical University; Clinipace Worldwide

Completed

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

Allergic Rhinitis

Taiwan
Advagene Biopharma Co. Ltd.
Gadjah Mada University

Terminated

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

COVID-19

Indonesia
Advagene Biopharma Co. Ltd.
Taipei Medical University Hospital

Completed

AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma

Eosinophilic Asthma

Taiwan

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe